跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 180 条关于
“ivacaftor-tezacaftor-elexacaftor”
全部
180
临床试验
141
药物
17
机构
0
资讯
22
去年
Elexacaftor–Tezacaftor–Ivacaftor Shows Promise for Cystic Fibrosis Patients Without F508del CFTR Variant
去年
Vertex's ALYFTREK Approved by FDA as Next-Generation Cystic Fibrosis Treatment
去年
NICE Recommends Vanzacaftor-Tezacaftor-Deutivacaftor for Cystic Fibrosis Treatment in England
2年前
TRIKAFTA Expanded by FDA to Treat Younger Cystic Fibrosis Patients and Additional Mutations
去年
Real-World Data Confirms Trikafta's Long-Term Efficacy as Gold Standard in Cystic Fibrosis Treatment
去年
Vertex Highlights Vanzacaftor Triple Combination Data and Long-Term TRIKAFTA Impact at NACFC
10个月前
Patient Advocacy Groups Launch Generic Cystic Fibrosis Drug Through Buyers' Club Model
9个月前
Cystic Fibrosis Patients on Triple-Drug Therapy Can Safely Reduce Daily Lung Treatments, Multi-Site Study Shows
去年
FDA Approves New Therapies for Hemophilia, Colorectal Cancer, and Cystic Fibrosis
9个月前
Trikafta Shows Sustained Anti-Inflammatory Effects in Cystic Fibrosis Patients Through 2.5 Years
第 1 页，共 3 页
上一页
下一页
